Havn Life Sciences Stock Net Income
| HAVLF Stock | USD 0.0001 0.00 0.00% |
As of the 10th of February, HAVN Life retains the coefficient of variation of 889.54, and Market Risk Adjusted Performance of (0.33). HAVN Life technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the entity's future prices. Please check out HAVN Life Sciences risk adjusted performance, standard deviation, as well as the relationship between the Standard Deviation and maximum drawdown to decide if HAVN Life is priced fairly, providing market reflects its last-minute price of 1.0E-4 per share. As HAVN Life Sciences appears to be a penny stock we also urge to confirm its information ratio numbers.
HAVN Life's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing HAVN Life's valuation are provided below:HAVN Life Sciences does not today have any fundamental trends for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. HAVN |
HAVN Life 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to HAVN Life's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of HAVN Life.
| 11/12/2025 |
| 02/10/2026 |
If you would invest 0.00 in HAVN Life on November 12, 2025 and sell it all today you would earn a total of 0.00 from holding HAVN Life Sciences or generate 0.0% return on investment in HAVN Life over 90 days. HAVN Life is related to or competes with Zelira Therapeutics, Ayala Pharmaceuticals, Sigyn Therapeutics, and Talis Biomedical. HAVN Life Sciences Inc., a biotechnology company, engages in the research and development of psychopharmacological produ... More
HAVN Life Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure HAVN Life's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess HAVN Life Sciences upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.112 | |||
| Maximum Drawdown | 1894.74 |
HAVN Life Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for HAVN Life's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as HAVN Life's standard deviation. In reality, there are many statistical measures that can use HAVN Life historical prices to predict the future HAVN Life's volatility.| Risk Adjusted Performance | 0.1001 | |||
| Jensen Alpha | 31.59 | |||
| Total Risk Alpha | 0.5004 | |||
| Treynor Ratio | (0.34) |
HAVN Life February 10, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1001 | |||
| Market Risk Adjusted Performance | (0.33) | |||
| Mean Deviation | 55.75 | |||
| Coefficient Of Variation | 889.54 | |||
| Standard Deviation | 222.81 | |||
| Variance | 49644.4 | |||
| Information Ratio | 0.112 | |||
| Jensen Alpha | 31.59 | |||
| Total Risk Alpha | 0.5004 | |||
| Treynor Ratio | (0.34) | |||
| Maximum Drawdown | 1894.74 | |||
| Skewness | 8.01 | |||
| Kurtosis | 64.81 |
HAVN Life Sciences Backtested Returns
HAVN Life is out of control given 3 months investment horizon. HAVN Life Sciences holds Efficiency (Sharpe) Ratio of 0.16, which attests that the company had a 0.16 % return per unit of volatility over the last 3 months. We were able to break down and interpolate sixteen different technical indicators, which can help you to evaluate if expected returns of 28.28% are justified by taking the suggested risk. Use HAVN Life Sciences coefficient of variation of 889.54, and Market Risk Adjusted Performance of (0.33) to evaluate company specific risk that cannot be diversified away. HAVN Life holds a performance score of 12 on a scale of zero to a hundred. The firm retains a Market Volatility (i.e., Beta) of -74.23, which attests to a somewhat significant risk relative to the market. As returns on the market increase, returns on owning HAVN Life are expected to decrease by larger amounts. On the other hand, during market turmoil, HAVN Life is expected to outperform it. Use HAVN Life Sciences standard deviation, as well as the relationship between the maximum drawdown and day median price , to analyze future returns on HAVN Life Sciences.
Auto-correlation | 0.00 |
No correlation between past and present
HAVN Life Sciences has no correlation between past and present. Overlapping area represents the amount of predictability between HAVN Life time series from 12th of November 2025 to 27th of December 2025 and 27th of December 2025 to 10th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of HAVN Life Sciences price movement. The serial correlation of 0.0 indicates that just 0.0% of current HAVN Life price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 0.17 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, HAVN Life Sciences reported net income of (22.44 Million). This is 106.58% lower than that of the Healthcare sector and 132.04% lower than that of the Biotechnology industry. The net income for all United States stocks is 103.93% higher than that of the company.
HAVN Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses HAVN Life's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of HAVN Life could also be used in its relative valuation, which is a method of valuing HAVN Life by comparing valuation metrics of similar companies.HAVN Life is currently under evaluation in net income category among its peers.
HAVN Fundamentals
| Return On Equity | -2.39 | |||
| Return On Asset | -0.37 | |||
| Operating Margin | (7.64) % | |||
| Current Valuation | 626.96 K | |||
| Shares Outstanding | 8.47 M | |||
| Shares Owned By Insiders | 2.77 % | |||
| Price To Book | 0.21 X | |||
| Price To Sales | 0.98 X | |||
| Revenue | 276.47 K | |||
| Gross Profit | 89.69 K | |||
| EBITDA | (21.8 M) | |||
| Net Income | (22.44 M) | |||
| Cash And Equivalents | 112.42 K | |||
| Cash Per Share | 0.02 X | |||
| Total Debt | 561.84 K | |||
| Debt To Equity | 0.03 % | |||
| Current Ratio | 0.18 X | |||
| Book Value Per Share | 0.11 X | |||
| Cash Flow From Operations | (7.88 M) | |||
| Earnings Per Share | (0.15) X | |||
| Beta | 0.0335 | |||
| Market Capitalization | 415.27 K | |||
| Total Asset | 4.06 M | |||
| Z Score | -16.5 | |||
| Net Asset | 4.06 M |
About HAVN Life Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze HAVN Life Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of HAVN Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of HAVN Life Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in HAVN Pink Sheet
HAVN Life financial ratios help investors to determine whether HAVN Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in HAVN with respect to the benefits of owning HAVN Life security.